← Open Payments lookup

CANDICE GRACE-LEE: Open Payments

NPI 1023070414 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$778 in 32 payments from 13 companies in 2025. Trend: 2023 $522 · 2024 $354 · 2025 $778

Food & beverage: $778
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.6$158
Lundbeck LLC5$116
Axsome Therapeutics, Inc.4$88
Vanda Pharmaceuticals Inc.3$80
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$80
Otsuka America Pharmaceutical, Inc.2$61
E.R. Squibb & Sons, L.L.C.2$50
Janssen Pharmaceuticals, Inc1$31
Supernus Pharmaceuticals, Inc.2$30
Teva Pharmaceuticals USA, Inc.1$24

Products named: INGREZZA, REXULTI, HETLIOZ, CAPLYTA, Sunosi, COBENFY, SPRAVATO, Qelbree.

Industry payments across MD — which companies pay providers there.